Empresa Pandion Therapeutics, Inc.
Acciones
PAND
US6983401067
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 56
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 56 | - |
Chief Tech/Sci/R&D Officer | - | 01/06/17 | |
John Sundy
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/20 |
Edward Freedman
COO | Chief Operating Officer | 55 | - |
Michelle Avery
IRC | Investor Relations Contact | - | 01/09/20 |
Anthony Mullin
HRO | Human Resources Officer | - | - |
Kevin Otipoby
PRN | Corporate Officer/Principal | - | - |
Vikas Goyal
PRN | Corporate Officer/Principal | 45 | 01/08/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 29 515 583 | 21 998 484 ( 74,53 %) | 0 | 74,53 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |